Loading data for MDCXW — first visit, this takes a few seconds.
Medicus Pharma Ltd. (MDCXW)
NasdaqCM: MDCXW
· Real-Time Price · USD
0.31
-0.08 (-20.51%)
At close: Sep 04, 2026, 7:53 PM
The price, the headline numbers and the latest news, in one place.
Medicus Pharma Ltd. (MDCXW) Stock Price, Analysis & Data
No data available
| Bid | 3.14 |
| Market Cap | n/a |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -56.7M |
| -0.48 | |
| n/a | |
| n/a | |
| n/a | |
| P/B (ttm) | -10.69 |
| P/S (ttm) | 0.00 |
| Earnings Date | n/a |
| Ask | 0.74 |
| Volume | 2,967 |
| Avg. Volume (20D) | 0 |
| Open | 0.99 |
| Previous Close | 0.39 |
| Day's Range | 0.30 - 0.31 |
| 52-Week Range | 0.30 - 2.50 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About MDCXW
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Part...
IPO Date Jul 17, 2026
Employees 16
Stock Exchange NasdaqCM
Ticker Symbol MDCXW
Website https://medicuspharma.com
Financial Performance
In 2025, Medicus Pharma's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -35.44M, an increase of 217.73%.
Financial StatementsEarnings Surprise
Medicus Pharma has released their quarterly earnings on Invalid Date:
- Revenue of n/a misses estimates by $0, with NaN% YoY growth.
- EPS of misses estimates by , with NaN% YoY growth.
Page 1 of 2